New trial aims to find best treatment for lung complication in rheumatoid arthritis
NCT ID NCT07643038
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This 52-week study will compare three drugs—tocilizumab, telitacicept, and methotrexate—in 204 people with rheumatoid arthritis who also have interstitial lung disease. The main goal is to see which drug best improves lung function. Participants will continue their usual arthritis medications during the trial.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Tocilizumab, telitacicept, and methotrexate
What this could lead to
If successful, this trial could identify a better treatment option for people with rheumatoid arthritis who also have lung disease, potentially slowing lung damage and improving breathing.
What could go wrong
This is a phase 4 study, so the drugs are already approved for other uses, but their effectiveness for this specific lung condition is unproven. The trial is not yet recruiting, and results may show no clear benefit or unexpected side effects.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RHEUMATOID ARTHRITIS ASSOCIATED INTERSTITIAL LUNG DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Affiliated Hospital of Inner Mongolia Medical University
Hohhot, China
Contact
Contact
-
Affiliated Hospital of Yan'an University
Yan’an, China
Contact
Contact
-
Beijing Chao-Yang Hospital, Capital Medical University
Beijing, China
Contact
Contact
-
China-Japan Friendship Hospital
Beijing, China
Contact
Contact
-
China-Japan Union Hospital of Jilin University
Changchun, China
-
Handan Central Hospital
Handan, China
Contact
Contact
-
Jiujiang No. 1 People's Hospital
Jiujiang, China
Contact
Contact
-
Peking Union Medical College Hospital
Beijing, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
-
People's Hospital of Ningxia Hui Autonomous Region
Yinchuan, China
Contact
Contact
-
Shanxi Bethune Hospital
Taiyuan, China
Contact
Contact
-
The First Affiliated Hospital of Anhui Medical University
Hefei, China
Contact
Contact
-
The First Affiliated Hospital of Army Medical University (Southwest Hospital)
Chongqing, China
Contact
Contact
-
The First Affiliated Hospital of Guangxi Medical University
Nanning, China
Contact
Contact
-
The First Affiliated Hospital of Henan University of Science and Technology
Luoyang, Henan, China
Contact
Contact
-
The First Affiliated Hospital of Nanjing Medical University
Nanjing, China
Contact
Contact
-
The First Affiliated Hospital of Xinjiang Medical University
Ürümqi, China
Contact
Contact
-
The Second Affiliated Hospital of Dalian Medical University
Dalian, China
Contact
Contact
-
The Second Affiliated Hospital of Nanchang University
Nanchang, China
Contact
Contact
-
The Second Affiliated Hospital, Zhejiang University School of Medicine
Hangzhou, China
Contact
Contact
-
The Second Hospital of Lanzhou University
Lanzhou, China
Contact
Contact
-
Xingyi People's Hospital
Xingyi, China
Contact
Contact
-
Xuanwu Hospital, Capital Medical University
Beijing, China
Contact
Contact